Author

Kevin J. Kerlin

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

2017 · William U. Shipley, Wendy Seiferheld, et al. · New England Journal of Medicine · 663

RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation

2015 · Beryl McCormick, Kathryn Winter, et al. · Journal of Clinical Oncology · 392

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902

2015 · Seth A. Rosenthal, Daniel Hunt, et al. · International Journal of Radiation Oncology*Biology*Physics · 75

Phase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02

2008 · Seth A. Rosenthal, Kyoungwha Bae, et al. · International Journal of Radiation Oncology*Biology*Physics · 66

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

2015 · W.U. Shipley, W. Seiferheld, et al. · International Journal of Radiation Oncology*Biology*Physics · 23

NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA.

2016 · William U. Shipley, Stephanie L. Pugh, et al. · Journal of Clinical Oncology · 17

A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)

2012 · Brian M. Alexander, Meihua Wang, et al. · Journal of Neuro-Oncology · 16

Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: A microarray study of RTOG C-0128

2008 · K. Zempolich, C. Fuhrman, et al. · Gynecologic Oncology · 15

A phase III protocol of androgen suppression (AS) and radiation therapy (RT) versus AS and RT followed by chemotherapy with paclitaxel, estramustine, and etoposide (TEE) for localized, high-risk, prostate cancer, RTOG 9902.

2010 · H. M. Sandler, D. Hunt, et al. · Journal of Clinical Oncology · 10

Preliminary Analysis of RTOG 9902: Increased Toxicity Observed with the Use of Adjuvant Chemotherapy

2005 · H.M. Sandler, M. DeSilvio, et al. · International Journal of Radiation Oncology*Biology*Physics · 10

Feasibility of RNA collection for micro-array gene expression analysis in the treatment of cervical carcinoma: a scientific correlate of RTOG C-0128

2005 · D.K. Gaffney, K. Winter, et al. · Gynecologic Oncology · 8

Changes in Gene Expression Induced by Chemoradiation in Advanced Cervical Carcinoma: A Microarray Study of RTOG C-0128

2005 · K. Zempolich, B. Milash, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

Induction chemotherapy using paclitaxel and carboplatin and thoracic radiation prior to surgery for locoregionally advanced non-small cell lung cancer: Results of a phase II trial

2004 · J. M. Leonardo, J. F. Moran, et al. · Journal of Clinical Oncology · 1

Feasibility of rna collection for micro-array gene expression analysis in the treatment of cervical carcinoma: A scientific correlate of RTOG c-0128

2004 · D.K. Gaffney, K. Winter, et al. · International Journal of Radiation Oncology*Biology*Physics

Feasibility of rna collection for micro-array gene expression analysis in the treatment of cervical carcinoma: A scientific correlate of RTOG c-0128

2004 · D GAFFNEY, K WINTER, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 15

Citation count: 1,297

H-index: 10

I10-index: 10